ATTD Breakthrough Outcomes Award

We are delighted to announce that submissions are now open for the ATTD Breakthrough Outcomes Award, supported by Eli Lilly and Company.

This award celebrates Primary Care teams that are leading the way in implementing best practices for people living with Type 2 diabetes in their everyday clinical care.

Who Can Apply?

  • Any healthcare professional can apply on behalf of their own Primary Care team.
  • You may also nominate another Primary Care team—with their consent.

PRIZE

Valued at €13,000 (including the ATTD 2026 registration, accommodation, and travel expenses).

APPLICATION
OPENS

1 October, 2025

APPLICATION
DEADLINE

15 November, 2025

What We’re Looking For

We invite submissions that highlight:

  • Innovative approaches to Type 2 diabetes management in Primary Care
  • Tangible improvements in patient outcomes
  • Sustainable practices that can inspire and be replicated by others

How to Apply

To enter, complete the submission form by answering a few key questions about your initiative, team, and outcomes. Supporting materials (e.g., publications, reports, links) may be included but are optional.

Timeline

  • 1 October, 2025: Award submissions open
  • 15 November, 2025: Award submissions close
  • January 2026: Awardee informed
  • 11-14 March, 2026: Award delivery during the ATTD 2026 Award Ceremony

Why Apply?

  • Gain international recognition at the world’s leading diabetes technology meeting
  • Showcase your team’s impact and inspire others in the field
  • Be part of advancing excellence in Primary Care for people with Type 2 diabetes